• OPEN AN ACCOUNT
Indian Indices
Sensex
73,895.74 315.20
( 0.43%)
Global Indices
Nasdaq
51,839.66 468.68
(0.91%)
Dow Jones
7,763.25 38.12
(0.49%)
Hang Seng
66,308.10 794.11
(1.21%)
Nikkei 225
10,694.57 14.58
(0.14%)
Forex
USD-INR
95.89 0.16
(0.16%)
EUR-INR
109.08 -0.12
(-0.11%)
GBP-INR
126.82 -0.30
(-0.24%)
JPY-INR
0.60 0.00
(-0.20%)

EQUITY - MARKET SCREENER

Industry :  
BSE Code
ISIN Demat
Book Value()
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
EPS(TTM)
Face Value()
Div & Yield %
 

novyra pharmachem ltd
Arvind consolidated net profit rises 5.74% in the March 2026 quarter
May 16,2026
Net profit of Arvind rose 5.74% to Rs 159.71 crore in the quarter ended March 2026 as against Rs 151.04 crore during the previous quarter ended March 2025. Sales rose 14.97% to Rs 2553.09 crore in the quarter ended March 2026 as against Rs 2220.69 crore during the previous quarter ended March 2025.

For the full year,net profit rose 17.10% to Rs 413.94 crore in the year ended March 2026 as against Rs 353.49 crore during the previous year ended March 2025. Sales rose 11.70% to Rs 9303.19 crore in the year ended March 2026 as against Rs 8328.81 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales2553.092220.69 15 9303.198328.81 12
OPM %11.9911.01 -10.8010.23 -
PBDT293.97227.41 29 902.64751.58 20
PBT216.41158.36 37 612.31492.87 24
NP159.71151.04 6 413.94353.49 17